Funding · Healthcare & Life Sciences
xStep raises undisclosed funding from Titan Capital
By Startup Enthusiast ·
- Date
- Company
- xStep
- What it does
- Non-invasive neurorehabilitation technology platform
- Kind
- Funding
- Amount
- Undisclosed
- Stage
- early
- Based in
- Bengaluru
What they do
XStep provides non-invasive neurorehabilitation solutions for patients with conditions like cerebral palsy, stroke, and spinal cord injuries using…
What happened
The company secured an undisclosed amount of funding from Titan Capital to support its commercial expansion and manufacturing scale-up in India
Why it matters
The startup operates an integrated neurorehabilitation center in Bengaluru and has treated over 1,000 individuals through its clinical programs and technology
The details
- The neurorehabilitation startup xStep secured an undisclosed investment from Titan Capital.
- This funding marks the first investment by Titan Capital into the company.
- The capital will support commercial expansion across India and the scaling of manufacturing operations.
- The company plans to use the funds to generate further clinical evidence and navigate regulatory requirements.
- xStep recently launched its first integrated neurorehabilitation experience centre in Bengaluru.
- The firm also partnered with Trexo Robotics to introduce wearable robotic gait trainers for children in India.
The bigger picture
- Neurological disorders remain a leading cause of long-term disability globally.
- Access to advanced rehabilitation technology is currently limited in many emerging markets.
- The company gained public visibility after being featured on Shark Tank India.
About the business
- xStep offers a non-invasive platform to treat neurological disorders including cerebral palsy and stroke.
- The technology uses spinal neuromodulation via skin electrodes to provide personalized therapy without surgery.
- The platform was developed by SpineX Inc. in the USA and is manufactured by VIVATRONIX Tech in India.
- The company has treated or supported over 1,000 individuals through its technology and clinical programs.
- It currently manages over 25 clinical studies and research collaborations across 20 countries.
What happens next
- Expand clinical collaborations both within India and internationally over the next 12 to 24 months.
- Develop new technologies that bridge the gap between academic research and patient care.
- Strengthen partnerships with clinicians, hospitals, and rehabilitation centers.
The deal
- Type
- funding
Investors
- Titan Capital (lead) — An investment firm participating in its first round for xStep.
Founders
- Dr. Parag Gad, Founder
Other articles talking about it
More on xStep
Same day
- Investors sell Eternal shares in large block deal1 September 2026 · Stake sale · ₹3,264.8 Cr
- BlackRock buys Ather shares worth ₹445.3 Cr in open market deal1 September 2026 · Stake sale · ₹445.3 Cr
- Zostel launches premium vertical Zo Selections1 September 2026 · Launch
- FirstCry market valuation falls below one billion dollars1 September 2026 · Unicorn
- Early.Partners launches three-week customer research sprint1 September 2026 · Launch
- Zepto postpones IPO, shifts strategy1 September 2026 · Policy